In agreement with the hypothesis, that MPG might be an important modulator of TMZ resistance in glioblastoma, it has been demonstrated that high levels of nuclear MPG expression detected in tumor samples of patients with glioblastoma correlated with poorer overall survival rates compared with patients who do not express the enzyme27. This evidence concerns the gene MPG and glioblastoma.